1. Pink Sheet
  2. >>Vaccines

DRC Gets First Mpox Vaccine Shipment & Issues EUA Ahead Of WHO Listing

 
• By Neena Brizmohun

The Democratic Republic of Congo, the country worst hit by the mpox crisis, has now received the first batch of vaccines for the disease. Meanwhile, the World Health Organization is expected to complete its review for emergency use listing of mpox vaccines soon.

The first mpox vaccines have arrived in the Democratic Republic of Congo • Source: Shutterstock

A large portion of the 215,000 or so doses of the mpox vaccine Jynneos that the EU and the product’s developer Bavarian Nordic are donating as an immediate response to the disease’s outbreak in Africa has arrived in the Democratic Republic of Congo.

Key Takeaways
  • A shipment of 99,100 doses of Bavarian Nordic’s mpox vaccine, Jynneos, has arrived in the Democratic Republic of Congo and another 100,900 doses are due to arrive on 7 September.
  • The shipment is part of the 215,000 or so doses of the vaccine that the EU and the company are donating as an immediate response to the disease’s outbreak

The first shipment of 99,100 doses of Jynneos (smallpox and monkeypox vaccine (live modified vaccinia virus Ankara)) was delivered in the DRC on 5 September and another 100,900 doses are due to arrive on 7

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Vaccines

Tougher Approval Standards May Follow Vinay Prasad’s Appointment To Lead US FDA’s CBER

 
• By Sarah Karlin-Smith

Industry is concerned that Prasad may make regulatory flexibility tougher to obtain for cell and gene therapy, while vaccine and public health advocates are angry about Prasad’s criticisms of US COVID-19 policies.

Moderna Pivots To Increase Focus On Cancer Amid US Vaccine Policy Changes

 
• By Joseph Haas

During its first quarter earnings call, Moderna avoided criticizing vaccine policy changes, but de-emphasized its flu/COVID-19 vaccine for those under age 50 and prioritized cancer programs.

How States And Courts Could Insulate America From An Anti-Vaccine Executive Branch

 
• By Sarah Karlin-Smith

The mood at the World Vaccines Congress in Washington, D.C. was bleak given Robert F. Kennedy Jr.’s rise to lead the Trump Administration’s Health and Human Services Department, but vaccine lawyers offered an optimistic outlook and ideas for countering his vaccine agenda.

Maybe In May: US FDA Calls Coming On Moderna Next-Gen COVID-19 Vaccine, AbbVie’s Big ADC Bet

 
• By Bridget Silverman

The 31 May goal date for Moderna’s next-generation COVID-19 vaccine looms over the month, but the US FDA's decision lineup includes three more novel agents, including AbbVie's Teliso-V antibody-drug conjugate, as well as supplemental indications like GSK's bid for Nucala in COPD.

More from Middle East & Africa

Japan Ships First Batch Of Mpox Vaccines To DRC

 
• By Lisa Takagi

Japan ships the first batch of 50,000 mpox vaccine doses to DRC after training local healthcare providers dealing with the persistent outbreak.

African Regulators Reach Big WHO Milestones

 
• By Francesca Bruce

Egypt is the first African country to win a WHO maturity level 3 benchmarking rating for medicines and vaccines that are locally produced and imported.

EU HTA Regulation: Views Wanted On Draft Rules On Joint Scientific Consultations

 
• By Francesca Bruce

A newly published draft implementing act sets out the procedural rules for the joint scientific consultations that are foreseen by the EU’s Health Technology Assessment Regulation.